DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy... Read more
MarketWatch
SeekingAlpha
CNBC
CNBC
Access detailed stock analysis from LSEG including analyst price target estimates.